These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 34930918)

  • 1. MAP4K4 mediates the SOX6-induced autophagy and reduces the chemosensitivity of cervical cancer.
    Huang H; Han Q; Zheng H; Liu M; Shi S; Zhang T; Yang X; Li Z; Xu Q; Guo H; Lu F; Wang J
    Cell Death Dis; 2021 Dec; 13(1):13. PubMed ID: 34930918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MAP4K4 and WT1 mediate SOX6-induced cellular senescence by synergistically activating the ATF2-TGFβ2-Smad2/3 signaling pathway in cervical cancer.
    Zheng H; Liu M; Shi S; Huang H; Yang X; Luo Z; Song Y; Xu Q; Li T; Xue L; Lu F; Wang J
    Mol Oncol; 2024 May; 18(5):1327-1346. PubMed ID: 38383842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNA-499a promotes the progression and chemoresistance of cervical cancer cells by targeting SOX6.
    Chen Y; Song Y; Mi Y; Jin H; Cao J; Li H; Han L; Huang T; Zhang X; Ren S; Ma Q; Zou Z
    Apoptosis; 2020 Apr; 25(3-4):205-216. PubMed ID: 31938895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Licochalcone A induces autophagy through PI3K/Akt/mTOR inactivation and autophagy suppression enhances Licochalcone A-induced apoptosis of human cervical cancer cells.
    Tsai JP; Lee CH; Ying TH; Lin CL; Lin CL; Hsueh JT; Hsieh YH
    Oncotarget; 2015 Oct; 6(30):28851-66. PubMed ID: 26311737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Period circadian regulator 2 suppresses drug resistance to cisplatin by PI3K/AKT pathway and improves chronochemotherapeutic efficacy in cervical cancer.
    Wang Z; Li F; He S; Zhao L; Wang F
    Gene; 2022 Jan; 809():146003. PubMed ID: 34648915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SOX6 represses tumor growth of clear cell renal cell carcinoma by HMG domain-dependent regulation of Wnt/β-catenin signaling.
    Chen L; Xie Y; Ma X; Zhang Y; Li X; Zhang F; Gao Y; Fan Y; Gu L; Wang L; Zhang X; Fu B
    Mol Carcinog; 2020 Oct; 59(10):1159-1173. PubMed ID: 32794610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MAP4K4 is a novel MAPK/ERK pathway regulator required for lung adenocarcinoma maintenance.
    Gao X; Chen G; Gao C; Zhang DH; Kuan SF; Stabile LP; Liu G; Hu J
    Mol Oncol; 2017 Jun; 11(6):628-639. PubMed ID: 28306189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Sox6 as a regulator of pancreatic cancer development.
    Jiang W; Yuan Q; Jiang Y; Huang L; Chen C; Hu G; Wan R; Wang X; Yang L
    J Cell Mol Med; 2018 Mar; 22(3):1864-1872. PubMed ID: 29369542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting MCL1 with Sanggenon C overcomes MCL1-driven adaptive chemoresistance via dysregulation of autophagy and endoplasmic reticulum stress in cervical cancer.
    Sun W; Cai H; Zhang K; Cui H; Zhao E
    Phytomedicine; 2024 Oct; 133():155935. PubMed ID: 39126925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of iASPP on chemoresistance through PLK1 and autophagy in ovarian clear cell carcinoma.
    Chan KK; Wong OG; Wong ES; Chan KK; Ip PP; Tse KY; Cheung AN
    Int J Cancer; 2018 Sep; 143(6):1456-1469. PubMed ID: 29663364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Butein sensitizes HeLa cells to cisplatin through the AKT and ERK/p38 MAPK pathways by targeting FoxO3a.
    Zhang L; Yang X; Li X; Li C; Zhao L; Zhou Y; Hou H
    Int J Mol Med; 2015 Oct; 36(4):957-66. PubMed ID: 26310353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tubeimoside I induces accumulation of impaired autophagolysosome against cervical cancer cells by both initiating autophagy and inhibiting lysosomal function.
    Feng X; Zhou J; Li J; Hou X; Li L; Chen Y; Fu S; Zhou L; Li C; Lei Y
    Cell Death Dis; 2018 Nov; 9(11):1117. PubMed ID: 30389907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osthole promotes the suppressive effects of cisplatin on NRF2 expression to prevent drug-resistant cervical cancer progression.
    Su J; Zhang F; Li X; Liu Z
    Biochem Biophys Res Commun; 2019 Jun; 514(2):510-517. PubMed ID: 31056260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD.
    Chen Y; Ke G; Han D; Liang S; Yang G; Wu X
    Exp Cell Res; 2014 Jan; 320(1):12-20. PubMed ID: 24183997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-box transcription factor TBX1, targeted by microRNA-6727-5p, inhibits cell growth and enhances cisplatin chemosensitivity of cervical cancer cells through AKT and MAPK pathways.
    Liu H; Song M; Sun X; Zhang X; Miao H; Wang Y
    Bioengineered; 2021 Dec; 12(1):565-577. PubMed ID: 33557670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PBK promotes aggressive phenotypes of cervical cancer through ERK/c-Myc signaling pathway.
    Ma H; Han F; Yan X; Qi G; Li Y; Li R; Yan S; Yuan C; Song K; Kong B
    J Cell Physiol; 2021 Apr; 236(4):2767-2781. PubMed ID: 33184870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin I promotes cisplatin resistance via Cdk5 activation in cervical cancer.
    Li R; Liu GZ; Luo SY; Chen R; Zhang JX
    Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4533-41. PubMed ID: 26698249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase C β inhibits autophagy and sensitizes cervical cancer Hela cells to cisplatin.
    Li N; Zhang W
    Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28246354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baicalein enhances cisplatin sensitivity in cervical cancer cells by promoting cuproptosis through the Akt pathway.
    Jin Y; Wu Q; Pan S; Zhou Q; Liu H; Zhang Q; Zhang J; Zhu X
    Biomed Pharmacother; 2024 Oct; 179():117415. PubMed ID: 39265236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of p14ARF-HDM2-p53 axis in SOX6-mediated tumor suppression.
    Wang J; Ding S; Duan Z; Xie Q; Zhang T; Zhang X; Wang Y; Chen X; Zhuang H; Lu F
    Oncogene; 2016 Mar; 35(13):1692-702. PubMed ID: 26119940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.